Literature DB >> 16287008

Prevalence of primary dysmenorrhea in Canada.

Margaret A Burnett1, Viola Antao, Amanda Black, Kymm Feldman, Andrew Grenville, Robert Lea, Guylaine Lefebvre, Odette Pinsonneault, Magali Robert.   

Abstract

OBJECTIVE: The aim of this study was to describe the prevalence, clinical effect, characteristics, and underlying risk factors of primary dysmenorrhea (PD) in Canada.
METHODS: A stratified, random sample of 2721 women 18 years and older was identified, and the women were interviewed by telephone. Data about menstrual symptoms and patterns and socio-demographic factors were obtained. The frequency, severity, and effect of menstrual pain were quantified. Logistic regression analysis was performed in order to identify independent risk factors for PD.
RESULTS: In the sample, 1546 women were having menstrual periods; of these, 934 (60%) met the criteria for PD. Sixty percent of the women with PD described their pain as moderate or severe. Fifty-one percent reported that their activities had been limited, and 17% reported missing school or work because of PD. The prevalence of PD decreased with increasing age (P < 0.001) and increased with smoking (P = 0.002). Users of oral contraceptives (OCs) tended to have less pain than non-users (P = 0.005). Socio-economic status, nulliparity, and earlier age at menarche were not independently associated with PD. However, nulliparous women, smokers, and women not using OCs were more likely to report disabling symptoms.
CONCLUSIONS: The majority of Canadian women will suffer from dysmenorrhea at some time during their reproductive years. Available prescription treatments are underused. Young age, smoking, and non-use of OCs are independent risk factors for PD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16287008     DOI: 10.1016/s1701-2163(16)30728-9

Source DB:  PubMed          Journal:  J Obstet Gynaecol Can        ISSN: 1701-2163


  55 in total

Review 1.  Dysmenorrhoea.

Authors:  Michelle L Proctor; Cynthia M Farquhar
Journal:  BMJ Clin Evid       Date:  2007-03-01

2.  Identification of experimental bladder sensitivity among dysmenorrhea sufferers.

Authors:  Kevin M Hellman; Avisek Datta; Nicole D Steiner; Julia N Kane Morlock; Ellen F Garrison; Daniel J Clauw; Frank F Tu
Journal:  Am J Obstet Gynecol       Date:  2018-04-25       Impact factor: 8.661

3.  Somatic symptoms in women with dysmenorrhea and noncyclic pelvic pain.

Authors:  Rebecca M Zuckerman; Rebecca L Silton; Frank F Tu; Joshua S Eng; Kevin M Hellman
Journal:  Arch Womens Ment Health       Date:  2018-03-10       Impact factor: 3.633

4.  Chronic Pain in a Biracial Cohort of Young Women.

Authors:  Octavia Plesh; Stuart A Gansky; Donald A Curtis
Journal:  Open Pain J       Date:  2012

5.  Gynecologic pain related to occupational stress among female factory workers in Tianjin, China.

Authors:  Kristin K Sznajder; Siobán D Harlow; Sarah A Burgard; Yanrang Wang; Cheng Han; Jing Liu
Journal:  Int J Occup Environ Health       Date:  2014 Jan-Mar

6.  Optimal management of chronic cyclical pelvic pain: an evidence-based and pragmatic approach.

Authors:  Ha Ryun Won; Jason Abbott
Journal:  Int J Womens Health       Date:  2010-08-20

Review 7.  Dysmenorrhea in adolescents: diagnosis and treatment.

Authors:  Linda French
Journal:  Paediatr Drugs       Date:  2008       Impact factor: 3.022

8.  Intraoperative detection of subtle endometriosis: a novel paradigm for detection and treatment of pelvic pain associated with the loss of peritoneal integrity.

Authors:  Bruce A Lessey; H Lee Higdon; Sara E Miller; Thomas A Price
Journal:  J Vis Exp       Date:  2012-12-21       Impact factor: 1.355

9.  Dysmenorrhoea in different settings: are the rural and urban adolescent girls perceiving and managing the dysmenorrhoea problem differently?

Authors:  Atchuta Kameswararao Avasarala; Saibharghavi Panchangam
Journal:  Indian J Community Med       Date:  2008-10

10.  Prevalence of dysmenorrhea and its effect on quality of life among a group of female university students.

Authors:  Alaettin Unsal; Unal Ayranci; Mustafa Tozun; Gul Arslan; Elif Calik
Journal:  Ups J Med Sci       Date:  2010-05       Impact factor: 2.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.